Victor E Nava
Overview
Explore the profile of Victor E Nava including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
395
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gesztes W, Mehrtash V, Nava V
Iran J Pathol
. 2025 Mar;
20(1):140-141.
PMID: 40060238
No abstract available.
2.
Hung S, Carpenay R, Fernandez X, Nava V
Mil Med
. 2025 Jan;
PMID: 39786786
Introduction: Massive transfusion protocols (MTPs) ensure the timely and life-saving delivery of blood products to patients who are rapidly exsanguinating. Although essential, MTPs are also highly resource-intensive. Effective MTP implementation...
3.
Lap C, Rajendran R, Martin J, Uppal M, Escobar A, Heiraty A, et al.
Ann Intern Med
. 2024 Nov;
177(12):1738-1741.
PMID: 39496182
No abstract available.
4.
Zara Rozalen A, Garcia R, Husami S, Marino G, Nava V
Tunis Med
. 2024 Oct;
102(10):730-734.
PMID: 39441158
Introduction: Granular cell tumors (GCT) are predominantly benign neoplasms composed by cells with abundant eosinophilic granular cytoplasm. Although the majority of GCTs exhibit a benign clinical course, a minority display...
5.
DeBoisblanc C, Nava V, Chauhan S, Joseph J
Cureus
. 2024 Apr;
16(3):e57080.
PMID: 38681357
Ankylosing spondylitis (AS) and systemic lupus erythematosus (SLE) are common rheumatologic ailments that cause multiorgan system disease. The incidence of lupus and AS in the same patient is rare and...
6.
Karel D, Valburg C, Woddor N, Nava V, Aggarwal A
Curr Oncol
. 2024 Apr;
31(4):1971-1993.
PMID: 38668051
Myelodysplastic neoplasms (MDS) are a heterogenous clonal disorder of hemopoietic stem cells characterized by cytomorphologic dysplasia, ineffective hematopoiesis, peripheral cytopenias and risk of progression to acute myeloid leukemia (AML). Our...
7.
Estephan F, Lap C, Banagan J, Antonio M, Liu S, Diao G, et al.
Ann Diagn Pathol
. 2024 Apr;
67:152219.
PMID: 38622987
Aims: Abnormalities in HER2 are well-established oncogenic drivers and are approved therapeutic targets in various malignancies. Prior studies evaluating HER2 expression in prostate cancer (PCa) have yielded variable results. Most...
8.
Zara Rozalen A, Martin J, Rajendran R, Jain M, Nava V
Curr Oncol
. 2024 Mar;
31(3):1556-1561.
PMID: 38534951
Ductal adenocarcinoma of the prostate (DAP) is an uncommon variant of prostate cancer associated with aggressive disease and poor outcome. It presents most frequently as a mixed tumor combined with...
9.
Alaithan H, Kumar N, Islam M, Liappis A, Nava V
Pharmaceutics
. 2023 Jul;
15(7).
PMID: 37513987
Malaria is a potentially fatal disease caused by protozoan parasites of the genus It is responsible for significant morbidity and mortality in endemic countries of the tropical and subtropical world,...
10.
Siddiqui G, Zara Rozalen A, Nava V
BMJ Case Rep
. 2023 Jun;
16(6).
PMID: 37295813
Mesonephric remnants (MRs) are embryonic vestiges most commonly found in female pathology specimens from the lateral wall of the cervix. The highly regulated genetic programme of mesonephric duct development has...